EVHEvolent Health, Inc.

NYSE evolenthealth.com


$ 30.27 $ -0.07 (-0.25 %)    

Monday, 16-Sep-2024 12:56:00 EDT
QQQ $ 471.70 $ -1.36 (-0.29 %)
DIA $ 416.34 $ -0.61 (-0.15 %)
SPY $ 561.39 $ -0.08 (-0.01 %)
TLT $ 101.13 $ 0.50 (0.49 %)
GLD $ 238.66 $ 0.06 (0.03 %)
$ 30.11
$ 30.34
$ 30.23 x 139
$ 30.30 x 200
$ 30.04 - $ 30.41
$ 17.98 - $ 35.00
1,299,491
na
3.5B
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-23-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-28-2020 03-31-2020 10-Q
19 03-02-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-03-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-16-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ast-spacemobile-and-polestar-automotive-are-among-top-10-best-performing-mid-cap-stocks-in-august-are-the-others-in-your-portfolio

The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, I...

 truist-securities-maintains-buy-on-evolent-health-maintains-33-price-target

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and maintains $33 price target.

 rbc-capital-reiterates-outperform-on-evolent-health-maintains-42-price-target

RBC Capital analyst Sean Dodge reiterates Evolent Health (NYSE:EVH) with a Outperform and maintains $42 price target.

 evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms

Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.

Core News & Articles

- Reuters Citing Sources

 jp-morgan-maintains-overweight-on-evolent-health-raises-price-target-to-45

JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $36 to ...

 jmp-securities-maintains-market-outperform-on-evolent-health-lowers-price-target-to-31

JMP Securities analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and lowers the price...

 truist-securities-upgrades-evolent-health-to-buy-raises-price-target-to-33

Truist Securities analyst Jailendra Singh upgrades Evolent Health (NYSE:EVH) from Hold to Buy and raises the price target fr...

 evolent-health-q2-2024-adj-eps-030-beats-026-estimate-sales-64714m-beat-63644m-estimate

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.26 by ...

 stephens--co-reiterates-overweight-on-evolent-health-maintains-42-price-target

Stephens & Co. analyst Jeff Garro reiterates Evolent Health (NYSE:EVH) with a Overweight and maintains $42 price target.

 canaccord-genuity-maintains-buy-on-evolent-health-lowers-price-target-to-41

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $44 ...

 jmp-securities-maintains-market-outperform-on-evolent-health-lowers-price-target-to-34

JMP Securities analyst Constantine Davides maintains Evolent Health (NYSE:EVH) with a Market Outperform and lowers the price...

 evolent-and-careology-form-partnership-to-enhance-cancer-care-in-the-us

Digital cancer care platform Careology and Evolent (NYSE:EVH) to offer an innovative platform to enable cancer navigationEvolen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION